US Stock MarketDetailed Quotes

CYTH Cyclo Therapeutics

Watchlist
  • 1.200
  • -0.010-0.83%
Close Apr 18 16:00 ET
34.46MMarket Cap-975P/E (TTM)

About Cyclo Therapeutics Company

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Company Profile

SymbolCYTH
Company NameCyclo Therapeutics
Listing DateDec 9, 2020
Founded1990
CEOMr. N. Scott Fine
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6714 NW 16th Street,Suite B
CityGainesville
ProvinceFlorida
CountryUnited States of America
Zip Code32653
Phone1-386-418-8060
Websitehttp://www.cyclotherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • N. Scott Fine
  • Director and Chief Executive Officer
  • 1.06M
  • Michael Lisjak
  • Chief Regulatory Officer and Senior Vice President, Business Development
  • 582.70K
  • Joshua M. Fine
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • 586.18K
  • Dr. Jeffrey L. Tate, PhD
  • Director and Chief Operating Officer
  • 218.19K
  • Markus W. Sieger
  • Chairman of the Board
  • 88.50K
  • F. Patrick Ostronic
  • Vice Chairman of the Board
  • 55.00K
  • William Conkling
  • Independent Director
  • --
  • Dr. Randall M. Toig
  • Independent Director
  • 47.50K
  • William S. Shanahan
  • Independent Director
  • 53.50K
  • C.E. Rick Strattan
  • Independent Director
  • 44.00K
  • Dr. Vivien Wong, PhD
  • Independent Director
  • --
  • Shawn Cross
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg